AXA stock keeps funding focus after EUR 750 million Tier 2 issue
Published on 11/11/2026 at 10:02 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSFunding and capital remain in focus
- AXA placed EUR 750 million of subordinated notes with institutional investors.
- The notes qualify as Tier 2 capital under Solvency II within applicable limits.
- The fixed coupon is 5.375% until May 25, 2037, before switching to a floating rate.
AXA announced on Wednesday, November 4, 2026, the placement of EUR 750 million of Reg S subordinated notes due in 2057 with institutional investors. In its press release, AXA said the transaction forms part of the group funding plan and that settlement was expected on November 6.
Funding plan supports capital position
The proceeds are intended for general corporate purposes, including the refinancing of part of AXA Group's outstanding debt. The structure gives the insurer another long-term funding instrument while supporting its regulatory capital position.
The notes carry a fixed annual interest rate of 5.375% until May 25, 2037, the first call date. After that date, the coupon is scheduled to become a floating rate based on three-month EURIBOR plus a margin of 295 basis points.
Tier 2 status shapes investor view
AXA said the notes qualify as Tier 2 capital under Solvency II. They are also expected to receive ratings of A from S&P Global Ratings and A1 (hyb) from Moody's. The issue therefore matters primarily for funding, debt refinancing and capital management rather than for near-term premium growth.
The most recently recorded AXA stock quote was 42.47 euros on Lang & Schwarz at 15:09 CET on Monday, October 26, 2026.
AXA stock at a glance
- Company: AXA S.A.
- ISIN: FR0000120628
- Capital-markets event: EUR 750 million Tier 2 notes due in 2057
- Quote: 42.47 euros on Lang & Schwarz, October 26, 2026, 15:09 CET
French equities are tracked in the CAC 40 market environment.
For investors, the bond placement adds visibility on AXA's refinancing calendar and capital structure. The next assessment will focus on how funding costs, solvency and insurance operating performance develop alongside the group's strategic plan.
